irAEs are more frequent and occur sooner in patients with autoimmune disease treated with anti-PD-1 (106, 107).Pre-existing autoimmune disease associated with modest increases in hospitalization with irAEs in patients treated with ICIs (108). Here, PDCD1 is linked to autoimmune disease.